1. Home
  2. ELAN vs BXSL Comparison

ELAN vs BXSL Comparison

Compare ELAN & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAN
  • BXSL
  • Stock Information
  • Founded
  • ELAN 1954
  • BXSL 2018
  • Country
  • ELAN United States
  • BXSL United States
  • Employees
  • ELAN N/A
  • BXSL N/A
  • Industry
  • ELAN Biotechnology: Pharmaceutical Preparations
  • BXSL Trusts Except Educational Religious and Charitable
  • Sector
  • ELAN Health Care
  • BXSL Finance
  • Exchange
  • ELAN Nasdaq
  • BXSL Nasdaq
  • Market Cap
  • ELAN 7.2B
  • BXSL 7.3B
  • IPO Year
  • ELAN 2018
  • BXSL N/A
  • Fundamental
  • Price
  • ELAN $13.99
  • BXSL $30.22
  • Analyst Decision
  • ELAN Buy
  • BXSL Buy
  • Analyst Count
  • ELAN 7
  • BXSL 6
  • Target Price
  • ELAN $16.17
  • BXSL $31.38
  • AVG Volume (30 Days)
  • ELAN 4.5M
  • BXSL 887.7K
  • Earning Date
  • ELAN 08-07-2025
  • BXSL 08-06-2025
  • Dividend Yield
  • ELAN N/A
  • BXSL 10.20%
  • EPS Growth
  • ELAN N/A
  • BXSL N/A
  • EPS
  • ELAN 0.75
  • BXSL 2.83
  • Revenue
  • ELAN $4,427,000,000.00
  • BXSL $1,398,444,000.00
  • Revenue This Year
  • ELAN $4.44
  • BXSL $9.58
  • Revenue Next Year
  • ELAN $4.79
  • BXSL $3.71
  • P/E Ratio
  • ELAN $18.59
  • BXSL $10.68
  • Revenue Growth
  • ELAN 1.42
  • BXSL 14.70
  • 52 Week Low
  • ELAN $8.02
  • BXSL $25.89
  • 52 Week High
  • ELAN $15.78
  • BXSL $34.64
  • Technical
  • Relative Strength Index (RSI)
  • ELAN 44.95
  • BXSL 35.70
  • Support Level
  • ELAN $13.39
  • BXSL $30.97
  • Resistance Level
  • ELAN $14.40
  • BXSL $32.20
  • Average True Range (ATR)
  • ELAN 0.40
  • BXSL 0.47
  • MACD
  • ELAN -0.13
  • BXSL -0.17
  • Stochastic Oscillator
  • ELAN 33.52
  • BXSL 18.03

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.

Share on Social Networks: